Here is a summary of current health newsletters.
Aging China presents plan to improve elderly care services
China is urging some local governments to embark on pilot programs to improve medical and care services for the elderly next year, with the goal of rolling out the program nationwide in 2023. Of the 31 provinces, Mainland China’s 15 regions and municipalities are expected to launch their local pilot projects for better medical and care services for the elderly next year, the National Health Commission (NHC) said on Monday.
90% of U.S. federal employees have received at least one dose of COVID-19 – officials
The White House is expected to announce Monday that more than 90% of the 3.5 million federal employees covered by a presidential mandate of COVID-19 vaccine have received at least one dose of vaccine before Monday’s deadline, told Reuters officials of the Biden administration. In total, the administration estimated that 95% of federal workers comply with its requirements in that they have been vaccinated or are in the process of completing vaccinations, or have a request for religious or medical exemption. pending, officials said.
Germany promotes ‘Rolls-Royce’ Moderna cliché to meet demand for COVID boosters
Germany will promote Moderna to Germans looking for booster vaccines as high demand for the BioNTech / Pfizer vaccine risks depleting stocks and derailing efforts to tame a fourth wave of the pandemic, Health Minister Jens Spahn said on Monday. Spahn warned at a press conference that some 16 million doses of Moderna could expire in the first quarter of next year if not used, adding that some experts see Moderna as the “Rolls-Royce” of vaccines. with BioNTech the “Mercedes”.
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, development of therapies
Chinese tech giant Baidu Inc on Monday announced that it had licensed its messenger RNA (mRNA) sequence algorithm to Sanofi SA for use in the design of vaccines and therapeutics, concluding its first such commercial agreement with a major global manufacturer of drugs. Sanofi was one of the world’s largest vaccine manufacturers before the pandemic, but the French company has been beaten by rivals BioNTech / Pfizer and Moderna in developing mRNA vaccines against COVID-19.
Activists urge Biden to push for IP waiver for COVID-19 vaccines
Fifteen human rights groups urge US President Joe Biden to personally engage in a long-term fight to enact an intellectual property waiver for COVID-19 vaccines at the World Trade Organization, calling his leadership “Moral necessity”. Amnesty International, Human Rights Watch, Oxfam, Public Citizen and 11 other groups told Biden in a letter that an emergency waiver was urgently needed to tackle the pandemic, noting that less than 7% of people in the low-income countries had received a first COVID. The -19 vaccine and vaccines have remained scarce.
World must support WHO and agree to pandemic treaty, panel says
The World Health Organization (WHO) must be strengthened with more funding and greater capacity to investigate pandemics through a new treaty, an independent panel said on Monday, ahead of a conference of health ministers on Monday. next week. Efforts to end the COVID-19 pandemic have been patchy and fragmented, marked by limited access to vaccines in low-income countries while “healthy and rich” in rich countries receive reminders, experts said high level in their last exam.
Czechs and Slovaks target unvaccinated people behind Austria
The Czech Republic and Slovakia banned unvaccinated people from pubs and services from Monday after an increase in COVID-19 cases filled hospital intensive care units, with most patients severely unvaccinated. vaccinated. Neighbors from central Europe both adopted the new measures last week, a step behind Austria which initially imposed restrictions on unvaccinated people, but opted for a full lockdown on Monday as the region experienced the last hotspot in the world.
First EU-donated COVID vaccine doses start arriving in Africa – GAVI
The first of nearly 100 million doses of the Johnson & Johnson COVID-19 vaccine donated by the European Union by the end of the year has started arriving in African countries, an alliance statement said on Monday. for GAVI vaccines. Belgium negotiated the deal as part of the bloc’s overall pledge to share at least 500 million doses with low and lower middle income countries by mid-2022, the Geneva-based group said, who is leading the COVAX initiative, in a press release.
Pfizer COVID-19 Vaccine Trial Data Shows Long-Term Effectiveness in Adolescents
Pfizer Inc said on Monday that its COVID-19 vaccine offered strong long-term protection against the virus in an advanced-stage study of adolescents aged 12 to 15. A two-dose series of the vaccine was 100% effective against COVID-19, measured from seven days to more than four months after the second dose, the company said.
(This story was not edited by Devdiscourse staff and is auto-generated from a syndicated feed.)